ADAM17 and sarcoma: Our analysis of ADAM17 mutations described in this study demonstrates the mutations we identified solely in metastatic SS through whole exome sequencing are desirable candidates for the studies with the goal to understand the metastatic process of SS, which in turn can lay the foundation for rational development of novel therapeutic strategies to improve the prognosis of this deadly sarcoma.